This higher ratiosuggests that sFlt-1 has a role in the development of hypoxia and inadequate angiogenesis in preeclamptic pregnancies.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Objective: It has been suggested that the underlying pathology in preeclampsia is inadequate trophoblastic invasion, abnormal placentation andextensive endothelial damage.
📊
Key Findings & Data:The aim of this study was to compare soluble Fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PGF)levels and sFlt-1/PGF ratio between preeclamptic and normotensive pregnant women, and to determine the increase in sFlt-1, which is an importantantiangiogenic factor in the development of preeclampsia.Methods: Following local ethics committee approval, this prospective study was carried out with 43 pregnant women, including 20 preeclamptic and23 normotensive pregnancies, who were admitted to our clinic.
💡
Conclusion & Impact:This higher ratiosuggests that sFlt-1 has a role in the development of hypoxia and inadequate angiogenesis in preeclamptic pregnancies.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Objective: It has been suggested that the underlying pathology in preeclampsia is inadequate trophoblastic invasion, abnormal placentation andextensive endothelial damage. The aim of this study was to compare soluble Fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PGF)levels and sFlt-1/PGF ratio between preeclamptic and normotensive pregnant women, and to determine the increase in sFlt-1, which is an importantantiangiogenic factor in the development of preeclampsia.Methods: Following local ethics committee approval, this prospective study was carried out with 43 pregnant women, including 20 preeclamptic and23 normotensive pregnancies, who were admitted to our clinic. The two groups were compared in terms of gestational characteristics, sFlt-1 levels,PGF levels and sFlt-1/PGF ratio.Results: Serum sFlt-1 levels and sFlt-1/PGF ratio were higher and serum PGF levels were lower in preeclamptic women compared to the control group.Conclusion: The sFlt-1/PGF ratio was significantly higher in preeclamptic pregnant women than in normotensive pregnant women. This higher ratiosuggests that sFlt-1 has a role in the development of hypoxia and inadequate angiogenesis in preeclamptic pregnancies.
🔖
Cite This Article
DEMİRAYAK, G., KILIK, T., ÇETİN, S. N. K., ŞAHİN, O., BULUT, B., MİHMANLI, V. (2022). Comparison of Maternal Serum Soluble Fms-Like Tyrosine Kinase-1/Placental Growth Factor Ratio in Preeclamptic and Normotensive Pregnant Women. European Archives of Medical Research, Cilt: 35 - Sayı: 2, 98–101. https://ajindex.com/articles/510421
Verlohren S, Galindo A, Schlembach D, Zeisler H, Herraiz I, Moertl MG, et al. An automated method for the determination of the sFlt-1/ PIGF ratio in the assesment of preeclampsia. Am J Obstet Gynecol 2010;202:161. e1-161. e11
National Collaborating Centre for Women’s and Children’s Health, Antenatal Care: Routine Care for the Healthy Pregnant Women. Clinical Guideline. Commissioned by the National Institute for Clinical Excellence. RCOG Press: London, UK. 2008;218-27
Dekker GA, Sibai BM. Pathogenesis and etiology of preeclampsia. Am J Obstet Gynecol 1998;179:1359
Mutter WP, Karumanchi SA. Molecular mechanisms of preeclampsia microvascular research 2008;75:1-8
Szpera Gozdziewicz A, Breborowicz GH. Endothelial dysfunction in the pathogenesis of preeclampsia. Front Biosci (Landmark Ed) 2014;19:736-46
Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, et al. Excess placental sflt-1 may contribute to endothelial dysfunction, hypertension and proteinuria in preeclampsia. J Clin Invest 2003;111:649- 58
Leanos-Miranda A, Campos-Galicia I, Ramirez-Valenzuela KL, Chinolla- Arellano ZL, Isordia-Salas I. Circulating angiogenic factors and urinary prolactin as predictors of adverse outcomes in women with preeclampsia. Hypertension 2013;61:1118-25
McElrath TF, Lim K- H, Pare E, Rich-Edwards J, Pucci D, Troisi R, et al. Longitudinal evaluation of predictive value for preeclampsia of circulating angiogenic factors through pregnancy. Am J Obstet Gynecol 2012;207:407. e1-7
Rana S, Powe CE, Salahuddin S, Verlohren S, Perschel FH, Levine RJ, et al. Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation 2012;125:911-9
Hunter R, Duckworth S, Seed P, Shennan A, Chappell L. PP051. Budget impact analysis of maternal plasma PIGF concentrations in women with suspected preeclampsia: the potential for improved health service usage. Pregnancy Hypertens 2013;3:85
Verlohren S, Stephan H, Dechend R. Angiogenic growth factors in the diagnosis and prediction of preeclampsia. Clin Sci 2012;122:43-52
Baltajian K, Bajracharya S, Salahuddin S, Berg AH, Geachchan C, Wenger JB, et al. Sequential plasma angiogenic factors levels in women with suspected preeclampsia. Am J Obstet Gynecol 2016;215:89 e1-9. e10
Zeisler H, Llurba E, Chantraine F, Vatish M, Staff AC, Sennstrom M, et al. Predictive value of the sFlt-1/PIGF ratio in women with suspected preeclampsia. N Engl J Med 2016;37